Letter to the EditorFGF 23 and risk of all-cause mortality and cardiovascular events: A meta-analysis of prospective cohort studies☆,☆☆,★
Section snippets
Conflict of interest
The authors report no relationships that could be construed as a conflict of interest.
References (26)
- et al.
Fibroblast growth factor 23 and risk of all-cause mortality and cardiovascular events: a meta-analysis of prospective cohort studies
Int J Cardiol
(2014) - et al.
Fibroblast growth factor-23 and death, heart failure, and cardiovascular events in community-living individuals: CHS (Cardiovascular Health Study)
J Am Coll Cardiol
(2012) - et al.
Intact fibroblast growth factor 23 levels predict incident cardiovascular event before but not after the start of dialysis
Bone
(2012) - et al.
FGF23 and risk of all-cause mortality and cardiovascular events: a meta-analysis of prospective cohort studies
Int J Cardiol
(2014) - et al.
Plasma FGF23 and the risk of stroke: the Northern Manhattan Study (NOMAS)
Neurology
(2014) - et al.
The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: the Heart and Soul Study
Ann Intern Med
(2010) - et al.
The Newcastle–Ottawa Scale (NOS) for assessing the quality of non-randomised studies in meta-analyses
- et al.
FGF-23 is associated with increased disease severity and early mortality in cardiogenic shock
Eur Heart J Acute Cardiovasc Care
(2013) - et al.
FGF-23 and future cardiovascular events in patients with chronic kidney disease before initiation of dialysis treatment
Nephrol Dial Transplant
(2010) - et al.
FGF-23 is associated with cardiac troponin T and mortality in hemodialysis patients
Hemodial Int
(2012)
Inorganic phosphate and FGF-23 predict outcome in stable systolic heart failure
Eur J Clin Invest
(2012)
Plasma fibroblast growth factor 23 concentration is increased and predicts mortality in patients on the liver-transplant waiting list
PLoS One
(2013)
Relationship between serum fibroblast growth factor-23 level and mortality in chronic hemodialysis patients
Int Urol Nephrol
(2014)
Cited by (5)
Fibroblast growth factor is associated to left ventricular mass index, anemia and low values of transferrin saturation
2015, NefrologiaCitation Excerpt :In a population study, non-sudden cardiac death is found to be associated with high FGF-2330. Recently in the meta-analysis of prospective cohort studies, a relationship between FGF-23 and all-cause mortality and cardiovascular events was observed31. However, additional studies are required to determine FGF-23 receptors that mediate the cardiac effects of FGF-23.
FGF 23 and risk of all-cause mortality and cardiovascular events: A meta-analysis of prospective cohort studies
2014, International Journal of CardiologyFibroblast Growth Factor 23 and Risk of New Onset Heart Failure With Preserved or Reduced Ejection Fraction: The PREVEND Study
2022, Journal of the American Heart AssociationRenal Clearance of Fibroblast Growth Factor-23 (FGF23) and its Fragments in Humans
2022, Journal of Bone and Mineral ResearchIntact and c-terminal FGF23 assays-do kidney function, inflammation, and low iron influence relationships with outcomes?
2020, Journal of Clinical Endocrinology and Metabolism
- ☆
Funding/support: None.
- ☆☆
Ethical review: Not applicable.
- ★
Statement of authorship: All authors have contributed to the critical revision of the manuscript for important intellectual content.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.